Provexis (LON:PXS) Announces Earnings Results

Provexis (LON:PXS) posted its earnings results on Thursday. The company reported GBX (0.02) EPS for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 44.78% and a negative net margin of 35.03%.

Provexis Stock Up 2.1%

LON:PXS opened at GBX 0.96 on Friday. Provexis has a twelve month low of GBX 0.55 and a twelve month high of GBX 1.55. The stock has a market cap of £22.52 million, a P/E ratio of -48.00 and a beta of 0.66. The business’s 50-day moving average price is GBX 1.05 and its two-hundred day moving average price is GBX 1.07.

About Provexis

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.